Blog

Meta Platforms’ META first-quarter 2026 results, set to be reported on April 29, are expected to reflect the benefits of higher advertising revenues. The Zacks Consensus Estimate for first-quarter

The HVAC and building systems space has become one of the more attractive corners of the U.S. construction market, helped by data center expansion, manufacturing reshoring, energy-efficiency

Shares of Blue Ridge Bankshares, Inc. BRBS have gained 2.6% since the company reported its earnings for the quarter ended March 31, 2026, modestly outperforming the S&P 500 Index’s 0.6% rise over

Quantum computing is steadily moving beyond academic theory into commercial reality, drawing increasing interest from corporations, governments and long-term investors seeking exposure to

An updated edition of the Jan. 16, 2026 article.Corporate leadership is undergoing a meaningful structural shift as more women assume top roles at publicly traded companies. This change is

The International Energy Agency (IEA) recently released its second-quarter 2026 Gas Market Report, revealing a stark transformation in global energy dynamics. According to the report, global

Shares of Intellia Therapeutics NTLA declined 4% on Monday despite positive top-line data from the global phase III HAELO clinical trial evaluating lonvo-z for the treatment of patients with

Amneal Pharmaceuticals AMRX is leaning into complex products and biosimilars to drive steadier growth. The 2026 setup centers on an elevated launch cadence in Affordable Medicines and expanding

The Procter & Gamble Company PG continues to execute an integrated growth strategy built around a portfolio of daily-use products where performance is critical. The company focuses on delivering

Cincinnati Financial Corporation's CINF reported first-quarter 2026 operating income of $2.10 per share, which surpassed the Zacks Consensus Estimate by 8.8%. The bottom line improved significantly

Brown & Brown, Inc.’s BRO first-quarter 2026 adjusted earnings of $1.39 per share beat the Zacks Consensus Estimate by 2.2%. The bottom line increased 7.8% year over year.

The quarterly results were

Ares Management ARES is scheduled to announce first-quarter 2026 results on May 1, before the opening bell. Its quarterly revenues and earnings are likely to have increased on a year-over-year

Alphabet’s GOOGL first-quarter 2026 results, scheduled to be released on April 29, are expected to have benefited from solid momentum in Search and Cloud businesses. The momentum in Search is

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock

SoFi Technologies, Inc. SOFI is scheduled to report its first-quarter 2026 results on April 29, before the bell.

The company has had an impressive earnings surprise history. Earnings surpassed the

Vertex Pharmaceuticals VRTX is scheduled to report its first-quarter 2026 results on May 4, after market close. The Zacks Consensus Estimate for the to-be-reported quarter’s revenues is pegged at

Eli Lilly and Company LLY announced a definitive agreement to acquire Ajax Therapeutics, a clinical-stage biotech focused on developing next-generation JAK inhibitors for the treatment of

SoFi Technologies, Inc. SOFI will report its first-quarter 2026 results on April 29, before the bell.

The Zacks Consensus Estimate for earnings in the to-be-reported quarter stands at 12 cents

Waste Connections, Inc. WCN reported impressive first-quarter 2026 results, with both earnings and revenues beating the Zacks Consensus Estimate.

WCN’s first-quarter earnings of $1.23 per share beat

Amneal Pharmaceuticals AMRX is coming off a strong 12-month run, but the stock’s valuation still screens as discounted versus key benchmarks. That combination can keep investor attention high

Amneal Pharmaceuticals AMRX is leaning into a playbook that can work in multiple market backdrops. The company is pairing steady demand in generics with higher-value opportunities in complex